Kairos Biosciences

Kairos Biosciences is a Salt Lake City, Utah–based regenerative medicine and surgical wound care company focused on enhancing acute surgical recovery. The company develops proprietary collagen and antimicrobial dressing technologies for high-risk surgical and wound environments. Primary product portfolio includes NuForra, a Type I collagen matrix powder featuring AngioReef™ technology with an 80–120 µm pore structure designed to support vascularization in complex surgical wounds, and PurForm AM, a silicone-backed antimicrobial foam dressing containing PHMB (Polyhexamethylene Biguanide) for post-operative wound management. Kairos targets community hospitals, long-term acute care hospitals (LTACHs), VA/DoD facilities, and specialized wound care centers. The company is DOBE-certified (Disabled Owned Business Enterprise), providing procurement advantages for distributor partners. Kairos emphasizes rapid innovation, proprietary formulation science, and patient-first product development with a lean organizational structure.